remodulin infusioonilahus
ferrer internacional s.a. - treprostiniil - infusioonilahus - 1mg 1ml 20ml 1tk
remodulin infusioonilahus
ferrer internacional s.a. - treprostiniil - infusioonilahus - 10mg 1ml 20ml 1tk
remodulin infusioonilahus
ferrer internacional s.a. - treprostiniil - infusioonilahus - 5mg 1ml 20ml 1tk
tresuvi infusioonilahus
orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 2,5mg 1ml 10ml 1tk
tresuvi infusioonilahus
orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 10mg 1ml 10ml 1tk
tresuvi infusioonilahus
orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 5mg 1ml 10ml 1tk
tresuvi infusioonilahus
orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 1mg 1ml 10ml 1tk
evrenzo
astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemilised preparaadid - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).
ondansetron kalceks süste-/infusioonilahus
kalceks as - ondansetroon - süste-/infusioonilahus - 2mg 1ml 2ml 25tk; 2mg 1ml 2ml 10tk; 2mg 1ml 2ml 5tk; 2mg 1ml 4ml 10tk
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - suguhormoonid ja immunoglobuliinid, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. vt lõigud 4. 4 ja 5.